Search

everythinglearnresearchcommunity

for

Search:↓

Oral retinoids can cause side effects ranging from mild to severe, including birth defects, and require careful monitoring and contraception.

HIV can cause unusual and severe skin problems that are hard to treat.

PRP injections may improve skin texture and wrinkles based on patient feedback, despite no significant changes seen by dermatologists.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

The document concludes that surgery is a preferred treatment for cicatricial alopecia, with the method chosen based on individual factors and may require multiple sessions and careful postoperative care.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

The document concludes that proper diagnosis and treatment of common scalp disorders are important for both physical and psychological health.

Hair loss in males involves inflammation, collagen buildup, and follicle damage, with severity increasing with age and baldness duration.

Using psychological treatments can help manage skin conditions along with regular medical care.

Oral contraceptives can cause skin issues like dark patches, acne, yeast infections, sensitivity to light, spider veins, skin rashes, and hair loss.

Hormones during pregnancy and lactation keep skin stem cells inactive, preventing hair growth.

Aging in hair follicle stem cells leads to hair graying, thinning, and loss.

Short anagen syndrome involves a hair growth phase lasting 1.5 years.

The article concludes that proper injection techniques and patient education can prevent serious skin reactions from multiple sclerosis medications.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

The document suggests that the traditional understanding of hair growth cycles and alopecia may be inaccurate and that blood supply plays a significant role in hair growth and loss.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Damaged hair follicle stem cells can cause permanent hair loss, but understanding their role could lead to new treatments.

Madarosis is the loss of eyelashes and eyebrows due to various health issues and requires thorough examination to diagnose and treat the underlying cause.

Aging alone barely affects the number of hair follicles, meaning hair loss is minimal without other conditions like androgenetic alopecia.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

Bariatric surgery affects skin health, causing both direct complications and changes in existing skin conditions, often related to nutritional deficiencies.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Eyebrow loss has many causes and requires accurate diagnosis for proper treatment.

Steven Kossard classified lymphocyte-related hair loss into four patterns, each linked to different types of baldness.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.